国产免费人成在线视频,国产亚洲精品美女久久久m,久久久综合九色合综国产精品,一本久久a久久免费不卡

      <i id="xqvzo"></i>

        <i id="xqvzo"></i>

        <acronym id="xqvzo"><bdo id="xqvzo"></bdo></acronym>
        R&D Capability
        Home Innovation

        R&D Capability

        R&D Capability

        Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

        • 7
          launched innovative drugs
        • 30 +
          innovative drug programs in different clinical stages
        • 50 +
          clinical trials of innovative drugs
        • 60 +
          national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
        • 2
          second prizes of National Science and Technology Progress Award
        • 2
          China Patent Gold Award
        • 600 +
          authorized invention patents at home and abroad
        • 200 +
          contributions to national standards
        R&D Team
        • 3
          State Council Special Allowance Experts
        • 16
          Jiangsu "innovative and entrepreneurial talent"
        • 9
          Jiangsu "333 talent project"
        • 1700 +
          R&D fellows in China and abroad